Novartis, continuing its string of expansions for radioligand therapy manufacturing, announced February 25 that it would ...
A raft of new tariffs announced by President Donald Trump included a 100% levy on imported pharmaceuticals unless their manufacturers are actively building factories in the U.S. In a series of ...
Last month, I discussed the potential engineers have to achieve post-COVID-19, high-performance health care. The pharmaceutical industry has touted high-performance IAQ long before COVID emerged. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results